newsfilter
← Latest News
PR Newswire·

Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology

CAMBRIDGE, Mass., Jan. 26, 2022 /PRNewswire/ -- Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent and tunable medicines, has appointed Stuart Milstein, Ph.D., to the newly created position of Senior Vice President